Healthcare Sector Stocks
The Healthcare sector has a total of 1048 stocks, with a combined market cap of $9.26 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 48.45.
Market Cap
9.26T
Revenue
4.67T
Profits
191.12B
PE Ratio
48.45
Profit Margin
4.10%
Dividend Yield
0.39%
1047 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.05T | 0.28% | 1,252,584 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 635.56B | 0.88% | 5,905,016 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 496.77B | 1.68% | 5,594,340 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 358.85B | -0.10% | 6,615,527 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 339.76B | -0.21% | 5,909,926 | 450.53B |
| 6 | NVS | Novartis AG | 273.22B | 0.06% | 1,149,716 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 246.42B | -0.55% | 2,855,678 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 244.86B | 0.64% | 1,384,870 | 46.34B |
| 9 | AMGN | Amgen Inc. | 225.75B | 0.65% | 1,720,672 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 186.53B | -0.49% | 6,254,770 | 30.46B |
| 11 | ABT | Abbott Laboratories | 176.19B | 2.23% | 7,146,997 | 46.59B |
| 12 | NVO | Novo Nordisk A/S | 169.42B | -0.16% | 8,722,171 | 50.34B |
| 13 | PFE | Pfizer Inc. | 161.87B | 0.42% | 18,555,612 | 63.70B |
| 14 | DHR | Danaher Corporation | 155.50B | 0.63% | 3,004,426 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 151.08B | 0.87% | 1,619,127 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 128.50B | -0.60% | 952,687 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 117.62B | -2.60% | 22,566,317 | 49.19B |
| 18 | MDT | Medtronic plc | 117.59B | 3.90% | 37,563,465 | 37.54B |
| 19 | CVS | CVS Health Corporation | 112.22B | 1.83% | 11,574,533 | 412.65B |
| 20 | MCK | McKesson Corporation | 111.43B | 1.80% | 646,953 | 410.98B |
| 21 | SYK | Stryker Corporation | 108.40B | 1.90% | 1,813,113 | 25.84B |
| 22 | HCA | HCA Healthcare, Inc. | 99.29B | 1.66% | 1,152,020 | 78.01B |
| 23 | SNY | Sanofi | 95.82B | -0.82% | 2,942,011 | 55.89B |
| 24 | GSK | GSK plc | 93.75B | 0.90% | 10,345,330 | 44.05B |
| 25 | ELV | Elevance Health, Inc. | 91.54B | 2.28% | 869,484 | 201.11B |
| 26 | MRNA | Moderna, Inc. | 85.33B | -5.00% | 12,910,240 | 2.23B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 76.17B | 2.18% | 618,087 | 15.53B |
| 28 | CI | The Cigna Group | 74.87B | 0.32% | 970,664 | 282.38B |
| 29 | BSX | Boston Scientific Corporation | 63.53B | 2.60% | 13,598,914 | 21.00B |
| 30 | COR | Cencora, Inc. | 62.03B | 0.37% | 959,159 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 58.92B | -0.27% | 1,908,841 | 28.42B |
| 32 | NTRA | Natera, Inc. | 57.34B | -0.73% | 934,700 | 2.71B |
| 33 | CAH | Cardinal Health, Inc. | 55.13B | 0.21% | 1,234,646 | 254.25B |
| 34 | HUM | Humana Inc. | 52.05B | 0.38% | 1,704,258 | 145.68B |
| 35 | BDX | Becton, Dickinson and Company | 51.45B | 2.80% | 1,184,416 | 22.48B |
| 36 | ARGX | argenx SE | 51.22B | -1.54% | 241,182 | 5.32B |
| 37 | EW | Edwards Lifesciences Corporation | 49.80B | 1.38% | 3,324,335 | 6.51B |
| 38 | A | Agilent Technologies, Inc. | 48.30B | 0.46% | 1,513,902 | 7.37B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 47.98B | 0.17% | 7,555,834 | 17.32B |
| 40 | VEEV | Veeva Systems Inc. | 47.90B | -0.09% | 1,137,680 | 3.46B |
| 41 | MDLN | Medline Inc. | 47.01B | -1.38% | 4,037,628 | 29.94B |
| 42 | IQV | IQVIA Holdings Inc. | 43.16B | 0.90% | 1,085,688 | 16.98B |
| 43 | WAT | Waters Corporation | 42.45B | -0.38% | 913,455 | 4.64B |
| 44 | ILMN | Illumina, Inc. | 41.78B | -0.54% | 1,642,744 | 4.49B |
| 45 | RVMD | Revolution Medicines, Inc. | 41.57B | 2.21% | 1,662,739 | - |
| 46 | HLN | Haleon plc | 41.29B | 1.93% | 19,371,463 | 14.80B |
| 47 | IDXX | IDEXX Laboratories, Inc. | 41.28B | 1.15% | 552,780 | 4.55B |
| 48 | ONC | BeOne Medicines AG | 39.84B | -1.15% | 259,301 | 6.13B |
| 49 | BIIB | Biogen Inc. | 33.90B | 1.64% | 1,461,587 | 10.03B |
| 50 | RPRX | Royalty Pharma plc | 33.22B | 1.49% | 2,465,332 | 2.54B |
| 51 | CNC | Centene Corporation | 33.11B | 2.54% | 3,508,279 | 180.30B |
| 52 | RMD | ResMed Inc. | 32.99B | 1.98% | 1,051,201 | 5.65B |
| 53 | DXCM | DexCom, Inc. | 32.42B | 2.15% | 2,991,915 | 4.97B |
| 54 | MTD | Mettler-Toledo International Inc. | 31.32B | 0.84% | 188,124 | 4.13B |
| 55 | ZTS | Zoetis Inc. | 31.26B | 1.12% | 4,089,660 | 9.53B |
| 56 | ALC | Alcon Inc. | 30.96B | 0.37% | 1,843,647 | 10.86B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 30.60B | 3.04% | 3,752,367 | 21.27B |
| 58 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.38B | -2.43% | 916,918 | 4.80B |
| 59 | WST | West Pharmaceutical Services, Inc. | 25.87B | 0.44% | 357,321 | 3.33B |
| 60 | DGX | Quest Diagnostics Incorporated | 25.68B | 0.72% | 865,230 | 11.56B |
| 61 | LH | Labcorp Holdings Inc. | 25.59B | 1.08% | 405,305 | 14.35B |
| 62 | ROIV | Roivant Sciences Ltd. | 24.99B | -2.40% | 4,734,660 | 7.53M |
| 63 | PHG | Koninklijke Philips N.V. | 24.22B | 2.06% | 1,213,034 | 20.18B |
| 64 | BNTX | BioNTech SE | 24.08B | -1.16% | 1,276,960 | 3.03B |
| 65 | UTHR | United Therapeutics Corporation | 23.59B | 0.17% | 840,632 | 3.15B |
| 66 | INCY | Incyte Corporation | 22.57B | -1.27% | 1,478,236 | 5.82B |
| 67 | GMAB | Genmab A/S | 22.20B | 0.81% | 3,127,573 | 4.13B |
| 68 | GH | Guardant Health, Inc. | 21.85B | -2.79% | 1,556,119 | 1.18B |
| 69 | THC | Tenet Healthcare Corporation | 21.64B | 1.89% | 510,003 | 21.81B |
| 70 | INSM | Insmed Incorporated | 21.52B | -2.03% | 1,696,057 | 1.14B |
| 71 | STE | STERIS plc | 21.35B | 2.14% | 725,948 | 6.04B |
| 72 | VTRS | Viatris Inc. | 20.15B | -0.57% | 7,550,515 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 17.58B | 3.40% | 1,799,266 | 8.51B |
| 74 | RVTY | Revvity, Inc. | 17.36B | 0.93% | 1,115,982 | 2.91B |
| 75 | MEDP | Medpace Holdings, Inc. | 17.31B | 1.31% | 171,704 | 2.78B |
| 76 | ASND | Ascendis Pharma A/S | 14.91B | -0.97% | 667,446 | 1.20B |
| 77 | EXEL | Exelixis, Inc. | 14.82B | -0.07% | 3,128,838 | 2.44B |
| 78 | SOLV | Solventum Corporation | 14.52B | -2.27% | 1,454,762 | 8.31B |
| 79 | CRL | Charles River Laboratories International, Inc. | 14.41B | 0.02% | 543,759 | 4.00B |
| 80 | NBIX | Neurocrine Biosciences, Inc. | 14.37B | -0.75% | 1,092,123 | 3.37B |
| 81 | JAZZ | Jazz Pharmaceuticals plc | 14.07B | -0.76% | 740,497 | 4.60B |
| 82 | SMMT | Summit Therapeutics Inc. | 13.70B | -2.62% | 4,375,684 | - |
| 83 | BTSG | BrightSpring Health Services, Inc. | 13.13B | -1.15% | 1,518,382 | 14.37B |
| 84 | CORT | Corcept Therapeutics Incorporated | 13.10B | - | 497,641 | 830.81M |
| 85 | BBIO | BridgeBio Pharma, Inc. | 12.85B | 0.61% | 1,778,921 | 713.07M |
| 86 | BAX | Baxter International Inc. | 12.81B | 1.77% | 5,234,336 | 11.47B |
| 87 | ICLR | ICON Public Limited Company | 12.68B | 0.14% | 853,331 | 8.29B |
| 88 | PEN | Penumbra, Inc. | 12.64B | 0.49% | 277,220 | 1.50B |
| 89 | HALO | Halozyme Therapeutics, Inc. | 12.61B | 0.60% | 1,629,480 | 1.66B |
| 90 | EHC | Encompass Health Corporation | 12.27B | 0.88% | 1,061,333 | 6.21B |
| 91 | TEM | Tempus AI, Inc. | 12.27B | -4.14% | 3,800,294 | 1.43B |
| 92 | DVA | DaVita Inc. | 11.59B | 1.41% | 586,374 | 14.01B |
| 93 | SNN | Smith & Nephew plc | 11.54B | 1.58% | 1,009,454 | 6.30B |
| 94 | TECH | Bio-Techne Corporation | 11.38B | 0.14% | 2,419,623 | 1.22B |
| 95 | ELAN | Elanco Animal Health Incorporated | 11.27B | -1.57% | 4,652,948 | 5.02B |
| 96 | FMS | Fresenius Medical Care AG | 11.22B | 0.71% | 692,121 | 22.19B |
| 97 | PCVX | Vaxcyte, Inc. | 11.12B | -1.02% | 2,427,438 | - |
| 98 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.79B | -0.97% | 469,262 | 1.28B |
| 99 | IBRX | ImmunityBio, Inc. | 10.73B | -3.71% | 11,057,088 | 165.79M |
| 100 | RDY | Dr. Reddy's Laboratories Limited | 10.72B | 2.72% | 2,155,149 | 3.50B |
| 101 | BMRN | BioMarin Pharmaceutical Inc. | 10.72B | 1.08% | 2,365,345 | 3.41B |
| 102 | MOH | Molina Healthcare, Inc. | 10.65B | 3.77% | 697,569 | 42.47B |
| 103 | COO | The Cooper Companies, Inc. | 10.56B | 2.16% | 3,393,787 | 4.24B |
| 104 | UHS | Universal Health Services, Inc. | 10.54B | 0.83% | 558,300 | 18.11B |
| 105 | OSCR | Oscar Health, Inc. | 10.49B | 1.92% | 5,783,939 | 15.32B |
| 106 | AVTR | Avantor, Inc. | 10.48B | -1.15% | 5,918,767 | 6.56B |
| 107 | GMED | Globus Medical, Inc. | 10.24B | 2.13% | 1,095,831 | 3.14B |
| 108 | ENSG | The Ensign Group, Inc. | 10.05B | 1.23% | 231,806 | 5.49B |
| 109 | ALGN | Align Technology, Inc. | 9.98B | -1.60% | 849,759 | 4.14B |
| 110 | GKOS | Glaukos Corporation | 9.91B | 1.41% | 881,892 | 612.84M |
| 111 | KRYS | Krystal Biotech, Inc. | 9.83B | 0.14% | 168,065 | 440.48M |
| 112 | TXG | 10x Genomics, Inc. | 9.80B | -6.77% | 4,079,902 | 616.91M |
| 113 | BIO | Bio-Rad Laboratories, Inc. | 9.74B | -0.48% | 181,201 | 2.59B |
| 114 | RGEN | Repligen Corporation | 9.74B | -0.79% | 899,597 | 785.10M |
| 115 | PODD | Insulet Corporation | 9.70B | 3.35% | 1,330,150 | 3.05B |
| 116 | TWST | Twist Bioscience Corporation | 9.52B | -4.96% | 2,652,331 | 431.80M |
| 117 | HSIC | Henry Schein, Inc. | 9.39B | 0.26% | 955,238 | 13.60B |
| 118 | PTGX | Protagonist Therapeutics, Inc. | 9.37B | 0.80% | 898,514 | 281.99M |
| 119 | QGEN | Qiagen N.V. | 9.37B | -0.15% | 1,171,567 | 2.10B |
| 120 | KYMR | Kymera Therapeutics, Inc. | 9.32B | -0.28% | 537,522 | 105.00M |
| 121 | CYTK | Cytokinetics, Incorporated | 8.73B | -0.19% | 1,254,058 | 67.67M |
| 122 | AXSM | Axsome Therapeutics, Inc. | 8.70B | -1.40% | 663,000 | 776.57M |
| 123 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.58B | -3.22% | 1,196,185 | 669.50M |
| 124 | BRKR | Bruker Corporation | 8.57B | -4.40% | 1,862,920 | 3.50B |
| 125 | HNGE | Hinge Health, Inc. | 8.46B | 1.87% | 1,344,545 | 720.06M |
| 126 | CAI | Caris Life Sciences, Inc. | 8.39B | -0.03% | 4,997,608 | 989.61M |
| 127 | SYRE | Spyre Therapeutics, Inc. | 8.03B | 0.25% | 873,906 | - |
| 128 | TGTX | TG Therapeutics, Inc. | 7.84B | -0.18% | 758,142 | 799.54M |
| 129 | ABVX | ABIVAX Société Anonyme | 7.62B | -1.37% | 658,939 | 5.33M |
| 130 | HQY | HealthEquity, Inc. | 7.61B | -0.63% | 610,857 | 1.36B |
| 131 | ATR | AptarGroup, Inc. | 7.56B | -1.19% | 476,753 | 3.93B |
| 132 | IONS | Ionis Pharmaceuticals, Inc. | 7.26B | -3.56% | 1,950,353 | 874.09M |
| 133 | HIMS | Hims & Hers Health, Inc. | 7.15B | -0.91% | 8,935,807 | 2.58B |
| 134 | PRAX | Praxis Precision Medicines, Inc. | 7.02B | -3.26% | 300,842 | 7.46M |
| 135 | PACS | PACS Group, Inc. | 7.01B | 2.31% | 538,972 | 5.55B |
| 136 | AMRX | Amneal Pharmaceuticals, Inc. | 6.98B | 0.60% | 4,588,204 | 3.12B |
| 137 | ALKS | Alkermes plc | 6.75B | -0.86% | 2,236,518 | 1.67B |
| 138 | GRFS | Grifols, S.A. | 6.67B | -1.21% | 266,105 | 8.48B |
| 139 | IOVA | Iovance Biotherapeutics, Inc. | 6.60B | -0.41% | 9,112,888 | 324.97M |
| 140 | LNTH | Lantheus Holdings, Inc. | 6.53B | -0.04% | 951,637 | 1.56B |
| 141 | CHE | Chemed Corporation | 6.52B | 0.16% | 119,697 | 2.60B |
| 142 | BLTE | Belite Bio, Inc | 6.39B | 2.65% | 259,180 | - |
| 143 | KOD | Kodiak Sciences Inc. | 6.23B | -0.61% | 1,325,817 | - |
| 144 | LGND | Ligand Pharmaceuticals Incorporated | 6.20B | 3.09% | 173,174 | 290.54M |
| 145 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.18B | -1.06% | 543,818 | 239.92M |
| 146 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.18B | -0.68% | 340,923 | 840.85M |
| 147 | GRAL | GRAIL, Inc. | 6.14B | -2.28% | 650,762 | 165.26M |
| 148 | IMVT | Immunovant, Inc. | 6.09B | -3.25% | 2,241,917 | - |
| 149 | BLCO | Bausch + Lomb Corporation | 5.74B | -7.11% | 3,014,271 | 5.32B |
| 150 | RDNT | RadNet, Inc. | 5.63B | 0.82% | 383,297 | 2.27B |
| 151 | CGON | CG Oncology, Inc. | 5.60B | -1.08% | 660,633 | 6.23M |
| 152 | MIRM | Mirum Pharmaceuticals, Inc. | 5.59B | 0.06% | 1,211,597 | 618.07M |
| 153 | HAE | Haemonetics Corporation | 5.55B | 2.84% | 895,092 | 1.35B |
| 154 | DOCS | Doximity, Inc. | 5.45B | 0.26% | 3,392,831 | 655.57M |
| 155 | ERAS | Erasca, Inc. | 5.41B | -3.56% | 4,280,347 | - |
| 156 | MMSI | Merit Medical Systems, Inc. | 5.36B | 2.91% | 859,796 | 1.58B |
| 157 | TFX | Teleflex Incorporated | 5.33B | 0.46% | 621,413 | 2.25B |
| 158 | ORKA | Oruka Therapeutics, Inc. | 5.32B | -2.14% | 547,856 | - |
| 159 | MMED | MiniMed Group, Inc. | 5.29B | -4.62% | 38,551,551 | 3.22B |
| 160 | STVN | Stevanato Group S.p.A. | 5.25B | -0.82% | 301,080 | 1.40B |
| 161 | PTCT | PTC Therapeutics, Inc. | 5.25B | -2.75% | 745,205 | 1.01B |
| 162 | SHC | Sotera Health Company | 5.18B | 0.50% | 1,560,513 | 1.22B |
| 163 | COGT | Cogent Biosciences, Inc. | 5.17B | -3.94% | 1,910,526 | - |
| 164 | MANE | Veradermics, Incorporated | 5.11B | -6.49% | 991,474 | - |
| 165 | WAY | Waystar Holding Corp. | 5.11B | -0.11% | 1,586,792 | 1.21B |
| 166 | SRRK | Scholar Rock Holding Corporation | 5.11B | -0.59% | 1,626,638 | - |
| 167 | CRSP | CRISPR Therapeutics AG | 4.98B | -3.45% | 1,106,241 | 13.39M |
| 168 | TVTX | Travere Therapeutics, Inc. | 4.90B | -0.21% | 1,424,335 | 591.33M |
| 169 | CON | Concentra Group Holdings Parent, Inc. | 4.79B | 0.94% | 1,003,158 | 2.29B |
| 170 | LFST | LifeStance Health Group, Inc. | 4.77B | 0.48% | 2,192,899 | 1.58B |
| 171 | DFTX | Definium Therapeutics, Inc. | 4.73B | -4.61% | 1,908,864 | - |
| 172 | OPCH | Option Care Health, Inc. | 4.66B | 0.10% | 4,835,801 | 5.69B |
| 173 | DNTH | Dianthus Therapeutics, Inc. | 4.56B | -0.97% | 853,947 | 1.90M |
| 174 | HTFL | HeartFlow, Inc. | 4.40B | 1.65% | 1,415,627 | 212.07M |
| 175 | BLLN | BillionToOne, Inc. | 4.39B | -5.12% | 490,249 | 397.41M |
| 176 | ITGR | Integer Holdings Corporation | 4.30B | -0.07% | 2,042,980 | 1.84B |
| 177 | LIVN | LivaNova PLC | 4.26B | 1.15% | 1,029,593 | 1.47B |
| 178 | INDV | Indivior Pharmaceuticals, Inc. | 4.26B | 0.64% | 7,474,011 | 1.33B |
| 179 | EWTX | Edgewise Therapeutics, Inc. | 4.18B | -1.56% | 1,536,698 | - |
| 180 | ICUI | ICU Medical, Inc. | 4.10B | 2.24% | 201,354 | 2.16B |
| 181 | ABCL | AbCellera Biologics Inc. | 4.09B | 0.68% | 5,756,294 | 66.17M |
| 182 | ADPT | Adaptive Biotechnologies Corporation | 4.08B | -3.47% | 3,117,227 | 308.08M |
| 183 | TNGX | Tango Therapeutics, Inc. | 4.08B | 1.51% | 2,867,916 | 53.81M |
| 184 | RLAY | Relay Therapeutics, Inc. | 3.94B | 0.56% | 2,090,794 | 10.35M |
| 185 | TLX | Telix Pharmaceuticals Limited | 3.86B | 0.71% | 266,212 | 890.79M |
| 186 | PLSE | Pulse Biosciences, Inc. | 3.74B | -2.53% | 434,319 | 1.19M |
| 187 | NVST | Envista Holdings Corporation | 3.65B | -1.22% | 2,392,906 | 2.86B |
| 188 | OGN | Organon & Co. | 3.62B | -0.29% | 932,349 | 6.13B |
| 189 | NHC | National HealthCare Corporation | 3.60B | 1.22% | 65,278 | 1.56B |
| 190 | PBLS | Parabilis Medicines, Inc. | 3.58B | 5.35% | 1,203,557 | 148.00K |
| 191 | VCYT | Veracyte, Inc. | 3.54B | -2.68% | 1,151,729 | 561.90M |
| 192 | RGC | Regencell Bioscience Holdings Limited | 3.54B | -2.99% | 131,187 | - |
| 193 | IRTC | iRhythm Holdings, Inc. | 3.52B | -0.02% | 384,396 | 825.34M |
| 194 | IDYA | IDEAYA Biosciences, Inc. | 3.48B | -0.14% | 441,471 | 234.13M |
| 195 | XENE | Xenon Pharmaceuticals Inc. | 3.47B | -1.73% | 764,362 | 7.50M |
| 196 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.45B | -2.35% | 1,106,088 | -665.00K |
| 197 | LEGN | Legend Biotech Corporation | 3.45B | -4.40% | 2,630,683 | 1.27B |
| 198 | ACAD | Acadia Pharmaceuticals Inc. | 3.34B | -1.87% | 1,184,727 | 1.14B |
| 199 | VKTX | Viking Therapeutics, Inc. | 3.31B | -0.60% | 2,861,930 | - |
| 200 | ARQT | Arcutis Biotherapeutics, Inc. | 3.30B | -1.35% | 1,556,740 | 463.98M |
| 201 | CDNA | CareDx, Inc. | 3.27B | -0.86% | 900,202 | 458.09M |
| 202 | TARS | Tarsus Pharmaceuticals, Inc. | 3.26B | 1.69% | 1,463,048 | 606.33M |
| 203 | CELC | Celcuity Inc. | 3.22B | -3.08% | 1,050,111 | - |
| 204 | WRBY | Warby Parker Inc. | 3.21B | 2.73% | 2,161,262 | 911.61M |
| 205 | RCUS | Arcus Biosciences, Inc. | 3.10B | -0.29% | 1,337,988 | 117.00M |
| 206 | DNLI | Denali Therapeutics Inc. | 3.03B | -2.57% | 1,231,411 | 3.60M |
| 207 | ELVN | Enliven Therapeutics, Inc. | 2.99B | -0.34% | 579,822 | - |
| 208 | DYN | Dyne Therapeutics, Inc. | 2.98B | -4.09% | 2,915,080 | - |
| 209 | ATRC | AtriCure, Inc. | 2.91B | 2.63% | 645,569 | 569.62M |
| 210 | ACHC | Acadia Healthcare Company, Inc. | 2.80B | 2.84% | 1,205,275 | 3.37B |
| 211 | ZLAB | Zai Lab Limited | 2.76B | -1.60% | 524,502 | 449.61M |
| 212 | PGEN | Precigen, Inc. | 2.74B | -1.92% | 2,163,254 | 85.72M |
| 213 | PRVA | Privia Health Group, Inc. | 2.74B | 2.88% | 1,413,766 | 2.36B |
| 214 | TMDX | TransMedics Group, Inc. | 2.71B | 0.39% | 491,900 | 668.47M |
| 215 | AVAH | Aveanna Healthcare Holdings Inc. | 2.66B | -0.33% | 1,756,269 | 2.60B |
| 216 | NEOG | Neogen Corporation | 2.62B | 1.27% | 2,570,500 | 884.00M |
| 217 | GRDN | Guardian Pharmacy Services, Inc. | 2.56B | -1.96% | 733,191 | 1.46B |
| 218 | NAMS | NewAmsterdam Pharma Company N.V. | 2.54B | -1.53% | 812,289 | 7.12M |
| 219 | CLOV | Clover Health Investments, Corp. | 2.54B | -0.21% | 3,899,171 | 2.48B |
| 220 | BEAM | Beam Therapeutics Inc. | 2.51B | -2.22% | 1,413,735 | 156.04M |
| 221 | MBX | MBX Biosciences, Inc. | 2.51B | -2.29% | 991,556 | - |
| 222 | SUPN | Supernus Pharmaceuticals, Inc. | 2.49B | 0.33% | 914,563 | 830.44M |
| 223 | LQDA | Liquidia Corporation | 2.48B | 1.06% | 4,414,322 | 450.91M |
| 224 | HCM | HUTCHMED (China) Limited | 2.47B | -2.98% | 43,780 | 549.12M |
| 225 | BKD | Brookdale Senior Living Inc. | 2.45B | 1.19% | 5,032,529 | 2.93B |
| 226 | SLS | SELLAS Life Sciences Group, Inc. | 2.41B | 2.40% | 4,035,091 | - |
| 227 | IRON | Disc Medicine, Inc. | 2.32B | -2.55% | 657,209 | - |
| 228 | PBH | Prestige Consumer Healthcare Inc. | 2.32B | 1.60% | 416,363 | 1.10B |
| 229 | CLDX | Celldex Therapeutics, Inc. | 2.31B | -1.54% | 596,401 | 158.00K |
| 230 | NRIX | Nurix Therapeutics, Inc. | 2.30B | -0.85% | 2,852,558 | 36.77M |
| 231 | UFPT | UFP Technologies, Inc. | 2.29B | 2.37% | 98,953 | 631.64M |
| 232 | ADMA | ADMA Biologics, Inc. | 2.28B | -1.74% | 1,627,324 | 512.28M |
| 233 | BFLY | Butterfly Network, Inc. | 2.28B | 3.64% | 3,856,948 | 112.14M |
| 234 | HRMY | Harmony Biosciences Holdings, Inc. | 2.23B | -5.09% | 1,148,356 | 959.90M |
| 235 | BHC | Bausch Health Companies Inc. | 2.22B | -1.82% | 2,540,776 | 10.85B |
| 236 | AUPH | Aurinia Pharmaceuticals Inc. | 2.20B | -0.60% | 654,764 | 311.51M |
| 237 | AXGN | Axogen, Inc. | 2.18B | 2.71% | 1,606,548 | 251.17M |
| 238 | IMNM | Immunome, Inc. | 2.18B | -2.05% | 835,816 | 4.02M |
| 239 | PHVS | Pharvaris N.V. | 2.17B | -0.68% | 646,018 | - |
| 240 | PGNY | Progyny, Inc. | 2.15B | 0.36% | 825,981 | 1.31B |
| 241 | RXRX | Recursion Pharmaceuticals, Inc. | 2.15B | -8.03% | 23,785,301 | 54.86M |
| 242 | PRGO | Perrigo Company plc | 2.14B | 2.59% | 1,840,202 | 4.14B |
| 243 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.14B | -2.22% | 3,466,867 | 940.61M |
| 244 | MD | Pediatrix Medical Group, Inc. | 2.14B | 1.05% | 487,325 | 1.95B |
| 245 | ADUS | Addus HomeCare Corporation | 2.11B | 1.00% | 194,238 | 1.48B |
| 246 | NVAX | Novavax, Inc. | 2.09B | -0.71% | 8,505,453 | 413.80M |
| 247 | NEO | NeoGenomics, Inc. | 2.08B | -0.92% | 1,183,635 | 766.30M |
| 248 | VCEL | Vericel Corporation | 2.08B | 1.30% | 432,876 | 306.30M |
| 249 | VRDN | Viridian Therapeutics, Inc. | 2.07B | -1.93% | 1,946,516 | 71.13M |
| 250 | INSP | Inspire Medical Systems, Inc. | 2.07B | 3.77% | 1,011,898 | 898.74M |
| 251 | ADRX | ADARx Pharmaceuticals, Inc. | 2.01B | 1.07% | 350,759 | 6.13M |
| 252 | TRLV | Trulieve Cannabis Corp. | 2.00B | -2.62% | 1,008,607 | 1.14B |
| 253 | VERA | Vera Therapeutics, Inc. | 2.00B | -7.23% | 1,405,607 | - |
| 254 | FTRE | Fortrea Holdings Inc. | 2.00B | 0.77% | 1,237,317 | 2.68B |
| 255 | MLYS | Mineralys Therapeutics, Inc. | 1.97B | -4.88% | 1,003,402 | - |
| 256 | ASTH | Astrana Health, Inc. | 1.97B | 2.26% | 294,544 | 3.84B |
| 257 | ALVO | Alvotech | 1.96B | -4.84% | 841,038 | 494.61M |
| 258 | SDGR | Schrödinger, Inc. | 1.94B | -5.02% | 2,151,525 | 259.04M |
| 259 | PVLA | Palvella Therapeutics, Inc. | 1.94B | -3.16% | 213,755 | - |
| 260 | LKFT | Lakefront Biotherapeutics NV | 1.92B | -0.54% | 220,249 | 1.13B |
| 261 | VIR | Vir Biotechnology, Inc. | 1.91B | -3.42% | 1,086,219 | 303.23M |
| 262 | XERS | Xeris Biopharma Holdings, Inc. | 1.91B | -0.19% | 1,328,510 | 335.41M |
| 263 | WGS | GeneDx Holdings Corp. | 1.90B | -5.21% | 491,119 | 454.43M |
| 264 | LMAT | LeMaitre Vascular, Inc. | 1.90B | 2.75% | 257,857 | 262.43M |
| 265 | URGN | UroGen Pharma Ltd. | 1.87B | 3.94% | 530,998 | 188.73M |
| 266 | MESO | Mesoblast Limited | 1.86B | -0.14% | 143,760 | 120.25M |
| 267 | XNCR | Xencor, Inc. | 1.86B | 1.66% | 753,049 | 104.97M |
| 268 | SGRY | Surgery Partners, Inc. | 1.85B | 2.52% | 1,212,434 | 3.37B |
| 269 | TRVI | Trevi Therapeutics, Inc. | 1.84B | -1.97% | 4,770,765 | - |
| 270 | SRPT | Sarepta Therapeutics, Inc. | 1.84B | -2.30% | 3,282,802 | 1.97B |
| 271 | AGIO | Agios Pharmaceuticals, Inc. | 1.84B | -3.11% | 770,047 | 98.34M |
| 272 | ESTA | Establishment Labs Holdings Inc. | 1.84B | -0.06% | 277,896 | 245.82M |
| 273 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.83B | -5.11% | 1,253,195 | 208.78M |
| 274 | ZYME | Zymeworks Inc. | 1.80B | -1.78% | 2,775,789 | 37.13M |
| 275 | BHVN | Biohaven Ltd. | 1.78B | -2.24% | 1,623,087 | - |
| 276 | GENB | Generate Biomedicines, Inc. | 1.78B | -3.49% | 676,047 | 26.48M |
| 277 | NTLA | Intellia Therapeutics, Inc. | 1.76B | -3.75% | 4,380,450 | 59.51M |
| 278 | SEPN | Septerna, Inc. | 1.75B | -2.11% | 207,561 | 98.88M |
| 279 | ATEC | Alphatec Holdings, Inc. | 1.74B | 5.44% | 2,950,036 | 815.05M |
| 280 | ZBIO | Zenas BioPharma, Inc. | 1.72B | -3.15% | 312,321 | 1.00M |
| 281 | NUVB | Nuvation Bio Inc. | 1.72B | -2.00% | 3,183,031 | 169.90M |
| 282 | NVCR | NovoCure Limited | 1.71B | 0.96% | 781,976 | 699.19M |
| 283 | SNDA | Sonida Senior Living, Inc. | 1.71B | 2.58% | 527,847 | 481.07M |
| 284 | GPCR | Structure Therapeutics Inc. | 1.71B | -6.38% | 1,662,563 | - |
| 285 | XRAY | DENTSPLY SIRONA Inc. | 1.70B | -3.40% | 4,689,838 | 3.64B |
| 286 | PSNL | Personalis, Inc. | 1.69B | -1.25% | 2,253,607 | 69.67M |
| 287 | ALMR | Alamar Biosciences, Inc. | 1.68B | -4.08% | 1,026,928 | 100.42M |
| 288 | OMCL | Omnicell, Inc. | 1.68B | 2.93% | 459,028 | 1.25B |
| 289 | ALHC | Alignment Healthcare, Inc. | 1.68B | 7.15% | 9,893,011 | 4.58B |
| 290 | BRVE | Braveheart Bio, Inc. | 1.66B | 1.70% | 155,072 | - |
| 291 | OCUL | Ocular Therapeutix, Inc. | 1.66B | 0.27% | 3,670,424 | 52.06M |
| 292 | ABSI | Absci Corporation | 1.66B | -4.82% | 2,861,609 | 1.56M |
| 293 | AZTA | Azenta, Inc. | 1.65B | 0.13% | 1,042,167 | 613.81M |
| 294 | ARDT | Ardent Health, Inc. | 1.63B | 2.04% | 574,186 | 6.41B |
| 295 | KMTS | Kestra Medical Technologies, Ltd. | 1.60B | -0.26% | 130,901 | 106.73M |
| 296 | CMPS | COMPASS Pathways plc | 1.60B | -3.92% | 1,960,359 | - |
| 297 | ETON | Eton Pharmaceuticals, Inc. | 1.58B | 0.07% | 436,754 | 105.60M |
| 298 | ANIP | ANI Pharmaceuticals, Inc. | 1.58B | -0.41% | 318,479 | 978.38M |
| 299 | STOK | Stoke Therapeutics, Inc. | 1.56B | -2.38% | 372,982 | 27.59M |
| 300 | KRSA | Korsana Biosciences, Inc. | 1.55B | 0.35% | 59,196 | - |
| 301 | INVA | Innoviva, Inc. | 1.55B | 1.13% | 521,191 | 440.00M |
| 302 | MAZE | Maze Therapeutics, Inc. | 1.54B | 2.18% | 1,437,792 | 20.00M |
| 303 | PAHC | Phibro Animal Health Corporation | 1.52B | -2.27% | 205,850 | 1.52B |
| 304 | QURE | uniQure N.V. | 1.51B | -3.32% | 1,409,279 | 18.67M |
| 305 | RARE | Ultragenyx Pharmaceutical Inc. | 1.50B | -1.16% | 2,898,536 | 717.00M |
| 306 | IMCR | Immunocore Holdings plc | 1.50B | -1.19% | 219,726 | 430.78M |
| 307 | SNDX | Syndax Pharmaceuticals, Inc. | 1.48B | -2.59% | 2,030,015 | 252.25M |
| 308 | KLRA | Kailera Therapeutics, Inc. | 1.47B | -2.41% | 1,220,797 | - |
| 309 | PCRX | Pacira BioSciences, Inc. | 1.45B | 0.11% | 2,007,342 | 746.16M |
| 310 | RAPP | Rapport Therapeutics, Inc. | 1.45B | -1.63% | 127,114 | 20.00M |
| 311 | AGL | agilon health, inc. | 1.44B | 3.76% | 158,669 | 5.92B |
| 312 | OMER | Omeros Corporation | 1.42B | -1.01% | 1,065,188 | 38.42M |
| 313 | FRNM | Freenome, Inc. | 1.42B | -16.22% | 1,625,361 | 35.41M |
| 314 | COAG | Hemab Therapeutics Holdings, Inc. | 1.42B | -3.89% | 235,030 | - |
| 315 | HCSG | Healthcare Services Group, Inc. | 1.42B | 0.19% | 595,114 | 1.86B |
| 316 | PNTG | The Pennant Group, Inc. | 1.42B | 1.99% | 208,924 | 1.10B |
| 317 | NUTX | Nutex Health Inc. | 1.41B | -0.07% | 122,451 | 846.72M |
| 318 | CERT | Certara, Inc. | 1.41B | 1.20% | 1,516,801 | 421.75M |
| 319 | AMN | AMN Healthcare Services, Inc. | 1.41B | -0.66% | 417,727 | 3.43B |
| 320 | AAPG | Ascentage Pharma Group International | 1.40B | 3.80% | 4,639 | 94.61M |
| 321 | ANAB | AnaptysBio, Inc. | 1.38B | 0.20% | 371,592 | 106.09M |
| 322 | GHRS | GH Research PLC | 1.37B | -5.16% | 229,891 | - |
| 323 | NKTR | Nektar Therapeutics | 1.36B | -3.23% | 1,048,220 | 54.59M |
| 324 | CNMD | CONMED Corporation | 1.36B | 2.12% | 515,221 | 1.37B |
| 325 | TSHA | Taysha Gene Therapies, Inc. | 1.35B | -7.80% | 4,214,236 | 5.49M |
| 326 | TYRA | Tyra Biosciences, Inc. | 1.35B | -1.71% | 334,395 | - |
| 327 | KARD | Kardigan, Inc. | 1.34B | -2.18% | 256,805 | - |
| 328 | OMDA | Omada Health, Inc. | 1.34B | 1.48% | 594,892 | 309.76M |
| 329 | INBX | Inhibrx Biosciences, Inc. | 1.33B | -4.72% | 329,402 | 1.30M |
| 330 | DRTS | Alpha Tau Medical Ltd. | 1.32B | -1.04% | 281,341 | - |
| 331 | USPH | U.S. Physical Therapy, Inc. | 1.28B | 1.49% | 104,444 | 804.27M |
| 332 | DMRA | Damora Therapeutics, Inc. | 1.25B | -3.91% | 267,877 | - |
| 333 | INNV | InnovAge Holding Corp. | 1.25B | 0.55% | 315,394 | 989.71M |
| 334 | REPL | Replimune Group, Inc. | 1.23B | -2.61% | 1,161,448 | - |
| 335 | SVRA | Savara Inc. | 1.23B | -1.63% | 1,306,603 | - |
| 336 | ORIC | ORIC Pharmaceuticals, Inc. | 1.22B | -1.50% | 878,260 | - |
| 337 | TRAX | First Tracks Biotherapeutics, Inc. | 1.22B | 6.91% | 7,311,821 | - |
| 338 | CRON | Cronos Group Inc. | 1.19B | -0.62% | 687,129 | 179.09M |
| 339 | NBTX | Nanobiotix S.A. | 1.19B | -1.18% | 173,276 | 13.15M |
| 340 | GDRX | GoodRx Holdings, Inc. | 1.19B | 1.46% | 815,584 | 785.23M |
| 341 | AHG | Akso Health Group | 1.17B | 9.60% | 25,583 | 13.83M |
| 342 | VOR | Vor Biopharma Inc. | 1.17B | -0.50% | 867,375 | - |
| 343 | LBRX | LB Pharmaceuticals Inc | 1.16B | -3.47% | 491,407 | - |
| 344 | BCAX | Bicara Therapeutics Inc. | 1.15B | -0.97% | 659,114 | - |
| 345 | TNDM | Tandem Diabetes Care, Inc. | 1.14B | 2.11% | 1,579,727 | 1.04B |
| 346 | IRMD | IRADIMED CORPORATION | 1.14B | 2.31% | 111,498 | 86.34M |
| 347 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.14B | 0.53% | 362,817 | 730.02M |
| 348 | BVS | Bioventus Inc. | 1.14B | 3.52% | 444,560 | 581.85M |
| 349 | PRCT | PROCEPT BioRobotics Corporation | 1.12B | 6.36% | 2,045,285 | 337.34M |
| 350 | JANX | Janux Therapeutics, Inc. | 1.11B | -1.31% | 802,945 | 24.00M |
| 351 | STAA | STAAR Surgical Company | 1.10B | 1.57% | 596,010 | 339.59M |
| 352 | AVLN | Avalyn Pharma Inc. | 1.10B | -3.73% | 133,319 | - |
| 353 | HROW | Harrow, Inc. | 1.09B | -0.85% | 577,024 | 275.59M |
| 354 | IART | Integra LifeSciences Holdings Corporation | 1.09B | 4.02% | 893,706 | 1.65B |
| 355 | TDOC | Teladoc Health, Inc. | 1.08B | 2.60% | 3,252,835 | 2.49B |
| 356 | AORT | Artivion, Inc. | 1.06B | 2.49% | 436,615 | 471.47M |
| 357 | LTGO | Latigo Biotherapeutics, Inc. | 1.06B | 0.12% | 132,996 | - |
| 358 | ENOV | Enovis Corporation | 1.05B | 3.17% | 910,921 | 2.30B |
| 359 | OPK | OPKO Health, Inc. | 1.03B | - | 1,011,531 | 587.90M |
| 360 | LMRI | Lumexa Imaging Holdings, Inc. | 1.03B | 1.33% | 185,449 | 1.04B |
| 361 | HSTM | HealthStream, Inc. | 1.02B | 1.00% | 159,680 | 321.12M |
| 362 | MNKD | MannKind Corporation | 1.01B | -4.86% | 3,958,086 | 393.63M |
| 363 | CSTL | Castle Biosciences, Inc. | 1.00B | -4.82% | 238,981 | 357.28M |
| 364 | MGTX | MeiraGTx Holdings plc | 996.93M | -2.90% | 506,494 | 397.50M |
| 365 | IMTX | Immatics N.V. | 985.53M | -2.96% | 750,365 | 47.65M |
| 366 | CBLL | CeriBell, Inc. | 969.43M | 6.90% | 697,034 | 101.96M |
| 367 | AKTS | Aktis Oncology, Inc. | 964.44M | -4.46% | 274,071 | 10.06M |
| 368 | CGEM | Cullinan Therapeutics, Inc. | 962.10M | -3.73% | 372,418 | - |
| 369 | ANRO | Alto Neuroscience, Inc. | 947.70M | -0.90% | 390,269 | - |
| 370 | BBNX | Beta Bionics, Inc. | 940.18M | 1.30% | 1,494,530 | 119.01M |
| 371 | KURA | Kura Oncology, Inc. | 924.75M | -1.93% | 1,212,862 | 77.23M |
| 372 | SPTX | Seaport Therapeutics, Inc. | 918.05M | -5.51% | 126,004 | - |
| 373 | ANL | Adlai Nortye Group Ltd. | 915.74M | -8.96% | 415,692 | 18.06M |
| 374 | ALMS | Alumis Inc. | 913.81M | -1.40% | 1,601,395 | 7.40M |
| 375 | RIGL | Rigel Pharmaceuticals, Inc. | 911.76M | -0.55% | 162,515 | 276.79M |
| 376 | MLTX | MoonLake Immunotherapeutics | 908.94M | -1.29% | 1,212,807 | - |
| 377 | QDEL | QuidelOrtho Corporation | 908.62M | -1.27% | 2,725,563 | 2.67B |
| 378 | SIBN | SI-BONE, Inc. | 900.85M | 3.77% | 553,647 | 213.60M |
| 379 | GLUE | Monte Rosa Therapeutics, Inc. | 897.50M | 2.14% | 2,094,583 | 28.73M |
| 380 | JBIO | Jade Biosciences, Inc. | 890.36M | -2.71% | 1,355,585 | - |
| 381 | ODTX | Odyssey Therapeutics, Inc. | 874.99M | -3.89% | 282,697 | 99.00K |
| 382 | SLBT | SL Science Holding Limited | 861.10M | - | 23,942 | 3.27M |
| 383 | CRVS | Corvus Pharmaceuticals, Inc. | 845.42M | -4.47% | 719,612 | - |
| 384 | SGP | SpyGlass Pharma, Inc. | 831.52M | -0.24% | 59,468 | - |
| 385 | GMRS | GMR Solutions Inc. | 823.85M | 2.12% | 1,479,468 | 5.88B |
| 386 | INMD | InMode Ltd. | 821.98M | 0.63% | 435,483 | 374.63M |
| 387 | ABUS | Arbutus Biopharma Corporation | 821.07M | -1.66% | 2,342,776 | 181.72M |
| 388 | AHCO | AdaptHealth Corp. | 819.13M | 1.32% | 1,533,478 | 3.36B |
| 389 | AVBP | ArriVent BioPharma, Inc. | 811.61M | -1.61% | 1,335,400 | - |
| 390 | HELP | Helus Pharma Inc. | 805.85M | -6.53% | 2,337,568 | - |
| 391 | ARDX | Ardelyx, Inc. | 804.88M | -1.52% | 3,537,394 | 450.89M |
| 392 | DNA | Ginkgo Bioworks Holdings, Inc. | 793.94M | -9.31% | 2,602,407 | 132.42M |
| 393 | OBX | Obsidian Therapeutics, Inc. | 790.08M | -1.62% | 420,004 | - |
| 394 | SANA | Sana Biotechnology, Inc. | 784.32M | -6.09% | 2,673,577 | - |
| 395 | GERN | Geron Corporation | 783.82M | -0.41% | 3,980,580 | 204.56M |
| 396 | VREX | Varex Imaging Corporation | 778.89M | 0.11% | 713,044 | 865.00M |
| 397 | IVA | Inventiva S.A. | 775.99M | -1.27% | 3,266,080 | 2.81M |
| 398 | APMD | Apnimed, Inc. | 775.58M | 0.59% | 301,029 | 115.12M |
| 399 | IMMX | Immix Biopharma, Inc. | 766.85M | -2.22% | 936,248 | - |
| 400 | ANNX | Annexon, Inc. | 750.73M | -1.49% | 1,927,485 | - |
| 401 | CADL | Candel Therapeutics, Inc. | 748.35M | -1.61% | 744,535 | - |
| 402 | VSTM | Verastem, Inc. | 747.15M | -1.55% | 3,637,895 | 87.53M |
| 403 | LXRX | Lexicon Pharmaceuticals, Inc. | 734.18M | -1.79% | 2,028,919 | 41.47M |
| 404 | GYRE | Gyre Therapeutics, Inc. | 727.92M | -2.49% | 81,952 | 109.82M |
| 405 | ACHV | Achieve Life Sciences, Inc. | 726.49M | -4.72% | 948,672 | - |
| 406 | SLDB | Solid Biosciences Inc. | 719.48M | -2.33% | 601,285 | - |
| 407 | FDMT | 4D Molecular Therapeutics, Inc. | 718.17M | -2.48% | 835,782 | 92.01M |
| 408 | COLL | Collegium Pharmaceutical, Inc. | 717.85M | -0.18% | 528,693 | 808.21M |
| 409 | AVTX | Avalo Therapeutics, Inc. | 710.06M | -3.00% | 502,773 | 59.00K |
| 410 | STLN | Starling Oncology, Inc. | 705.26M | 4.37% | 965,455 | 587.24M |
| 411 | MDXG | MiMedx Group, Inc. | 704.02M | 3.43% | 625,570 | 355.17M |
| 412 | OABI | OmniAb, Inc. | 693.51M | -0.42% | 988,495 | 38.46M |
| 413 | PHAR | Pharming Group N.V. | 691.81M | -1.84% | 7,509 | 366.48M |
| 414 | CTKB | Cytek Biosciences, Inc. | 690.21M | -2.21% | 1,036,682 | 206.71M |
| 415 | DSGN | Design Therapeutics, Inc. | 682.77M | -6.35% | 304,299 | - |
| 416 | AURA | Aura Biosciences, Inc. | 678.23M | - | 613,137 | - |
| 417 | ZVRA | Zevra Therapeutics, Inc. | 672.22M | -0.61% | 509,036 | 136.07M |
| 418 | PHR | Phreesia, Inc. | 671.61M | 0.09% | 533,230 | 507.79M |
| 419 | ATTO | Attovia Therapeutics, Inc. | 666.05M | -9.99% | 262,316 | 1.80M |
| 420 | PACB | Pacific Biosciences of California, Inc. | 652.74M | -9.87% | 12,083,875 | 159.27M |
| 421 | AVR | Anteris Technologies Global Corp. | 648.33M | -1.77% | 972,548 | 2.24M |
| 422 | WVE | Wave Life Sciences, Inc. | 646.32M | -5.20% | 2,257,958 | 65.37M |
| 423 | OLMA | Olema Pharmaceuticals, Inc. | 643.98M | -5.88% | 1,018,746 | - |
| 424 | PRME | Prime Medicine, Inc. | 642.23M | -9.52% | 3,138,100 | 4.07M |
| 425 | NVCT | Nuvectis Pharma, Inc. | 641.53M | -6.77% | 145,827 | - |
| 426 | SGMT | Sagimet Biosciences Inc. | 624.00M | -1.46% | 1,157,408 | - |
| 427 | CLYM | Climb Bio, Inc. | 622.03M | -1.55% | 911,845 | - |
| 428 | IRWD | Ironwood Pharmaceuticals, Inc. | 621.30M | -1.57% | 1,035,815 | 389.32M |
| 429 | CBIO | Crescent Biopharma, Inc. | 618.90M | -3.02% | 153,894 | 11.88M |
| 430 | SOPH | SOPHiA GENETICS SA | 614.62M | -2.56% | 478,873 | 86.17M |
| 431 | STTK | Shattuck Labs, Inc. | 611.21M | 2.01% | 1,024,547 | 1.00M |
| 432 | AQST | Aquestive Therapeutics, Inc. | 603.71M | 0.63% | 957,305 | 54.09M |
| 433 | FTH | Faeth Therapeutics, Inc. | 600.79M | -10.68% | 309,822 | - |
| 434 | FLGT | Fulgent Genetics, Inc. | 590.75M | -1.24% | 227,945 | 323.93M |
| 435 | WEAV | Weave Communications, Inc. | 590.39M | - | 381,888 | 257.79M |
| 436 | ETRA | Electra Therapeutics, Inc. | 584.99M | 3.10% | 346,735 | - |
| 437 | CRMD | CorMedix Inc. | 581.46M | 1.08% | 1,591,778 | 462.25M |
| 438 | SLN | Silence Therapeutics plc | 581.02M | -2.13% | 550,981 | 615.00K |
| 439 | KIDS | OrthoPediatrics Corp. | 576.50M | 1.99% | 178,432 | 252.72M |
| 440 | PHAT | Phathom Pharmaceuticals, Inc. | 566.34M | -1.66% | 1,013,672 | 239.66M |
| 441 | DBVT | DBV Technologies S.A. | 561.29M | -2.55% | 311,779 | 5.04M |
| 442 | VALN | Valneva SE | 559.92M | 2.60% | 10,515 | 163.30M |
| 443 | BLSM | BlossomHill Therapeutics, Inc. | 548.93M | -1.20% | 91,059 | - |
| 444 | DCTH | Delcath Systems, Inc. | 543.73M | 2.02% | 207,452 | 95.42M |
| 445 | DRUG | Bright Minds Biosciences Inc. | 533.01M | -0.07% | 134,579 | - |
| 446 | PBYI | Puma Biotechnology, Inc. | 531.17M | - | 284,790 | 231.24M |
| 447 | ACRS | Aclaris Therapeutics, Inc. | 529.92M | -6.01% | 3,428,934 | 8.22M |
| 448 | CTMX | CytomX Therapeutics, Inc. | 527.32M | -5.84% | 4,001,203 | 18.30M |
| 449 | MNPR | Monopar Therapeutics Inc. | 517.17M | -2.42% | 133,189 | - |
| 450 | RGNX | REGENXBIO Inc. | 512.92M | -3.72% | 2,033,551 | 174.48M |
| 451 | TCMD | Tactile Systems Technology, Inc. | 512.39M | 0.80% | 178,230 | 350.31M |
| 452 | EOLS | Evolus, Inc. | 511.89M | 0.26% | 1,002,227 | 316.49M |
| 453 | SSII | SS Innovations International, Inc. | 510.98M | -3.59% | 64,302 | 52.40M |
| 454 | RZLT | Rezolute, Inc. | 510.85M | - | 1,009,632 | - |
| 455 | PROK | ProKidney Corp. | 504.88M | -4.02% | 607,771 | 818.00K |
| 456 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 457 | ALT | Altimmune, Inc. | 497.97M | -1.92% | 2,159,732 | 31.00K |
| 458 | SGHT | Sight Sciences, Inc. | 493.86M | 0.84% | 348,542 | 83.38M |
| 459 | TLRY | Tilray Brands, Inc. | 492.79M | -5.08% | 3,887,400 | 963.10M |
| 460 | EPRX | Eupraxia Pharmaceuticals Inc. | 491.01M | -1.88% | 250,662 | - |
| 461 | NGNE | Neurogene Inc. | 489.08M | -7.42% | 388,006 | 925.00K |
| 462 | MASS | 908 Devices Inc. | 488.56M | -1.91% | 230,915 | 60.84M |
| 463 | SENS | Senseonics Holdings, Inc. | 488.56M | 2.90% | 452,238 | 48.55M |
| 464 | EVO | Evotec SE | 488.45M | -10.46% | 182,465 | 819.47M |
| 465 | ARVN | Arvinas, Inc. | 487.13M | -2.49% | 502,648 | 316.70M |
| 466 | OCS | Oculis Holding AG | 486.45M | -5.52% | 283,958 | 1.45M |
| 467 | ALLO | Allogene Therapeutics, Inc. | 483.69M | -4.11% | 4,316,472 | 4.64M |
| 468 | EVH | Evolent Health, Inc. | 480.50M | 5.20% | 1,184,576 | 2.10B |
| 469 | ANGO | AngioDynamics, Inc. | 479.42M | -1.04% | 1,083,128 | 325.38M |
| 470 | MPLT | MapLight Therapeutics, Inc. | 477.95M | -2.60% | 485,234 | - |
| 471 | OVID | Ovid Therapeutics Inc. | 470.67M | -2.03% | 875,974 | 1.58M |
| 472 | TKNO | Alpha Teknova, Inc. | 467.09M | -1.58% | 159,184 | 43.70M |
| 473 | ASMB | Assembly Biosciences, Inc. | 463.61M | -3.23% | 207,819 | 74.85M |
| 474 | BWAY | BrainsWay Ltd. | 463.19M | -2.63% | 158,284 | 60.70M |
| 475 | AUTL | Autolus Therapeutics plc | 463.12M | -3.87% | 1,054,818 | 117.39M |
| 476 | ENTX | Entera Bio Ltd. | 458.83M | -0.38% | 305,688 | 42.00K |
| 477 | KMDA | Kamada Ltd. | 456.46M | -2.97% | 42,717 | 191.85M |
| 478 | CERS | Cerus Corporation | 455.45M | -1.74% | 1,179,801 | 221.55M |
| 479 | NRC | NRC Health | 451.46M | 0.39% | 48,668 | 140.00M |
| 480 | YDES | YD Bio Limited | 448.36M | -5.94% | 138,120 | 1.24M |
| 481 | AGMB | AgomAb Therapeutics NV | 447.66M | 0.11% | 58,979 | - |
| 482 | NPCE | NeuroPace, Inc. | 446.22M | 2.60% | 63,301 | 106.99M |
| 483 | DMAC | DiaMedica Therapeutics Inc. | 442.19M | -1.56% | 185,593 | - |
| 484 | TECX | Tectonic Therapeutic, Inc. | 436.93M | -4.20% | 103,919 | - |
| 485 | CAPR | Capricor Therapeutics, Inc. | 434.30M | -4.60% | 1,460,239 | 11.13M |
| 486 | PRTA | Prothena Corporation plc | 433.28M | -4.52% | 489,758 | 54.53M |
| 487 | EDIT | Editas Medicine, Inc. | 422.35M | -5.17% | 1,297,432 | 47.01M |
| 488 | SPRY | ARS Pharmaceuticals, Inc. | 415.69M | -1.18% | 1,274,263 | 116.93M |
| 489 | RCEL | AVITA Medical, Inc. | 413.49M | 1.21% | 319,237 | 75.63M |
| 490 | CTEV | Claritev Corporation | 412.33M | -1.34% | 118,788 | 994.67M |
| 491 | CARL | Carlsmed, Inc. | 403.53M | 2.50% | 36,857 | 63.30M |
| 492 | AVIR | Atea Pharmaceuticals, Inc. | 403.43M | -2.33% | 190,704 | - |
| 493 | MYGN | Myriad Genetics, Inc. | 401.73M | -2.55% | 1,381,056 | 806.60M |
| 494 | SRTA | Strata Critical Medical, Inc. | 401.64M | 0.22% | 773,245 | 255.98M |
| 495 | CYH | Community Health Systems, Inc. | 395.74M | 5.80% | 1,074,723 | 11.98B |
| 496 | EIKN | Eikon Therapeutics, Inc. | 393.24M | -2.81% | 236,188 | - |
| 497 | SCTX | Scribe Therapeutics Inc. | 391.32M | -2.36% | 512,197 | 33.30M |
| 498 | GALT | Galectin Therapeutics Inc. | 390.29M | -1.78% | 99,664 | - |
| 499 | IRD | Opus Genetics, Inc. | 386.03M | -0.22% | 1,624,066 | 9.86M |
| 500 | PRLD | Prelude Therapeutics Incorporated | 385.20M | -3.86% | 196,547 | 22.42M |